Rezolute (RZLT) Change in Account Payables (2011 - 2026)
Rezolute (RZLT) reported Change in Account Payables of -$587000.0 for Q1 2026, down 117.5% on a YoY basis from $3.4 million in Q1 2025, and down 212.02% sequentially from $524000.0 in Q4 2025.
Rezolute (RZLT) Change in Account Payables (2011 - 2026) Analysis & Trends
Rezolute (RZLT) has 13 years of Change in Account Payables data on file, last reported at -$587000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 117.5% year-over-year to -$587000.0; the trailing twelve-month figure through Mar 2026 stood at -$3.3 million (down 210.12% YoY), and the FY2025 full-year result was $1.4 million, up 31.21% from the prior year.
- Change in Account Payables slipped to -$587000.0 in Q1 2026, from $524000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $3.4 million in Q1 2025 to a low of -$2.8 million in Q1 2022.
- A 5-year average of -$74647.1 and a median of -$22000.0 in 2022 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables slumped 3700.0% in 2023 and surged 3630.53% in 2025, its largest moves.
- Tracing RZLT's Change in Account Payables over 5 years: stood at $1.7 million in 2022, then sank by 32.89% to $1.2 million in 2023, then retreated by 14.64% to $991000.0 in 2024, then slumped by 47.12% to $524000.0 in 2025, then tumbled by 212.02% to -$587000.0 in 2026.
- Business Quant data shows RZLT's Change in Account Payables at -$587000.0 in Q1 2026, $524000.0 in Q4 2025, and -$2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,561.01 Bn | 66,560.72 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 469.79 Bn | 465.00 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 122.95 Bn | 115.70 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.62 Bn | 62.62 Bn | - | - |
| 8 | Argenx Se | 56.18 Bn | 50.99 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.86 Mn |
| 10 | Rezolute | 506.68 Mn | 506.68 Mn | - | -587,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -587,000.00 |
| Mar 31, 2026 | -587,000.00 |
| Dec 31, 2025 | 524,000.00 |
| Dec 31, 2025 | 524,000.00 |
| Sep 30, 2025 | -2.52 Mn |
| Sep 30, 2025 | -2.52 Mn |
| Jun 30, 2025 | -730,000.00 |
| Jun 30, 2025 | -730,000.00 |
| Mar 31, 2025 | 3.35 Mn |
| Mar 31, 2025 | 3.35 Mn |
| Dec 31, 2024 | 991,000.00 |
| Dec 31, 2024 | 991,000.00 |
| Sep 30, 2024 | -2.19 Mn |
| Sep 30, 2024 | -2.19 Mn |
| Jun 30, 2024 | 853,000.00 |
| Jun 30, 2024 | 853,000.00 |
| Mar 31, 2024 | -95,000.00 |
| Mar 31, 2024 | -95,000.00 |
| Dec 31, 2023 | 1.16 Mn |
| Dec 31, 2023 | 1.16 Mn |